Healthcare

WHO calls for stronger ethical oversight of AI in health research

The WHO urged stronger ethical oversight of AI-enabled health research, emphasizing transparency, bias, privacy, accountability and human rights.

The World Economic Forum’s health briefing reports that the World Health Organization called for stronger ethical oversight of AI in health research. The WHO warned that innovation should not outpace safeguards for human rights, equity, privacy and public trust.

The recommendations apply across the research lifecycle and involve researchers, ethics committees, regulators, funders and publishers. The WHO said these groups need stronger scrutiny of AI-enabled research practices.

The report identifies transparency, bias, accountability and potential harms as issues requiring greater expertise and resources. It also notes that pharmaceutical companies are increasing investment in AI for drug discovery, molecule design and clinical-trial planning.

This development matters because it links healthcare-AI adoption with governance requirements. As AI becomes more involved in biomedical research and pharmaceutical development, the WHO’s position calls for institutions to assess not only technical performance but also fairness, privacy and accountability.

Original source: World Economic Forum

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI